Outcome Capital Announces UCB Pharma Has Acquired Beryllium Discovery

08:00 EDT 6 Jun 2017 | Businesswire
This article has expired, however you can still download the PDF.
Outcome Capital, an investment banking firm that serves middle market growth companies in the life science and technology segments, today announced that UCB Pharma, Ltd. has acquired privately held Beryllium Discovery, LLC. Bery...

Other Sources for this Article

Bioscribe, Inc.
Nicole Litchfield, 1-415-793-6468


More From BioPortfolio on "Outcome Capital Announces UCB Pharma Has Acquired Beryllium Discovery"

Quick Search

Relevant Topics

Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...

Searches Linking to this Story